University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Rescriptor

Rescriptor (delavirdine)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."
gray line
transparent gif

Approved adult dosing

four 100 mg tablets, three times a day

  • Morning

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

  • Mid-day

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

  • Evening

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

two 200 mg tablets, three times a day

  • Morning

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

  • Mid-day

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

  • Evening

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

Notes on taking this medication

  • No food restrictions, can take with or without food
  • Rescriptor interacts with many other drugs; persons using Rescriptor with those drugs may need an adjustment to their dose of Rescriptor or the other drugs; consult your medical provider

Side effects

  • Rash (usually occurs within first 3 weeks of starting drug)
  • Liver inflammation and increased liver enzyme levels
  • Headache; fatigue; stomach upset

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

transparent gif
Contents
transparent gifScroll over drug name to see other names for the drug.
transparent gif
transparent gif
transparent gif